Generated by AI
Clearmind Medicine Inc. Common Shares represents equity in Clearmind Medicine Inc., a clinical-stage biotechnology company focused on developing novel psychedelic-derived therapeutics and neuroplastogen-based compounds for underserved health conditions. The company’s current work centers on researching and advancing treatments for alcohol use disorder and related behavioral health indications, using proprietary small-molecule drug candidates designed to target underlying neurobiological pathways. Clearmind Medicine also operates consumer-oriented and research-driven programs tied to its therapeutic platform, reflecting a broader approach that combines pharmaceutical development with adjacent product concepts. Based in Vancouver, Canada, with active research and development activities in Israel, Clearmind Medicine participates in the life sciences market through a specialized pipeline aimed at regulated medicine development. Its common shares are used by investors to gain exposure to the company’s ongoing biotech research, clinical programs, and intellectual property-driven business model.
Website1220 West 6th Avenue
Vancouver, BC, V6H 1A5
Canada
The latest articles about CMND.
The U.S. Patent Applications Cover Proprietary Combinations of NeuroThera's PEA Technology With LSD, Ketamine and Ibogaine for Potential Therapeutic Applications, Including Mental Health Disorders, Such as Depression and PTSD as Well as Substance Use...
The U.S. patent applications cover proprietary combinations of NeuroThera’s PEA technology with LSD, ketamine and ibogaine for potential therapeutic applications, including mental health disorders, such as depression and PTSD as well as substance use disorders TEL AVIV, Israel, Sept. 23, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developi
Summary of Sep 17's posts. Generated by AI.
Summary of Aug 31's posts. Generated by AI.
Summary of May 29's posts. Generated by AI.
Summary of Sep 4's posts. Generated by AI.
Investors talking about CMND also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.